A 1.5 million-participant study of incident cardiovascular disease shows that more than one-half of cases and about one-fifth of related deaths result from 5 modifiable
American adolescents who tried to stop using e-cigarettes in 2021 most commonly did so without assistance, a study shows, cessation methods varied according to the
A proposed rule announced by the FDA to limit the nicotine concentration in combustible cigarettes ignores the delivery device used most commonly by youths: e-cigarettes.
Commenting on a cluster-randomized trial in which nicotine-replacement products were offered to smokers during screenings for lung cancer, an editorialist describes such events as not
A nonprescription agent used outside the United States, the naturally occurring plant-based alkaloid cytisinicline (historically known as cytisine) is used by patients 6 times daily
FDA should consider differences in how tobacco products are marketed to and used by people of different biological sexes and gender identities as it develops
The novel Motivation And Problem Solving (MAPS) treatment produced a 2-fold increase in smoking abstinence among survivors of cervical intraepithelial neoplasia (CIN) or cervical cancer at
The 2022–23 influenza vaccine has provided reasonable protection against infection and hospitalization caused by infection, members of the CDC’s Advisory Committee on Immunization Practices heard
Among individuals with smoking exposure with and without COPD, a study identifies “risk factors for suicide/overdose … that emphasize the subjective experience of illness over
FDA has issued a final guidance, “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research, Guidance for Industry.” This guidance provides the FDA’s current thinking on